Suzanne Nielsen

Summary

Publications

  1. ncbi request reprint The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids
    Suzanne Nielsen
    Discipline of Addiction Medicine, University of Sydney, Sydney, NSW, Australia
    Med J Aust 199:696-9. 2013
  2. pmc A comparison of buprenorphine taper outcomes between prescription opioid and heroin users
    Suzanne Nielsen
    UCLA Integrated Substance Abuse Programs, Los Angeles, CA, USA
    J Addict Med 7:33-8. 2013
  3. doi request reprint Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization
    Suzanne Nielsen
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia The Langton Centre, South East Sydney Local Health District SESLHD Drug and Alcohol Services, Sydney, New South Wales, Australia
    Pain Med 16:356-66. 2015
  4. doi request reprint The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain
    Gabrielle Campbell
    aNational Drug and Alcohol Research Centre, School of Medicine, University of New South Wales, Sydney, Australia bThe Langton Centre, South East Sydney Local Health District SESLHD Drug and Alcohol Services, Surry Hills, Australia cSchool of Medicine, University of Tasmania, Sandy Bay Campus, Hobart, Australia dUniversity of Sydney, Addiction Medicine, Central Clinical School, Camperdown, Australia eSt Vincent s Clinical School, University of New South Wales, Darlinghurst, Australia fCentre for Youth Substance Abuse Research, Royal Brisbane and Women s Hospital, University of Queensland, Herston, Australia gSchool of Population and Global Health, The University of Melbourne, Melbourne, Australia hMurdoch Childrens Research Institute, The Royal Children s Hospital, Parkville, Australia iDepartment of Global Health, School of Public Health, University of Washington, Seattle, WA, USA
    Pain 156:231-42. 2015
  5. pmc Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology
    Larissa J Mooney
    UCLA Integrated Substance Abuse Programs, Los Angeles, CA 90025, USA
    Contemp Clin Trials 34:196-204. 2013
  6. pmc Cohort protocol paper: the Pain and Opioids In Treatment (POINT) study
    Gabrielle Campbell
    National Drug and Alcohol Research Centre, UNSW, Sydney, NSW 2052, Australia
    BMC Pharmacol Toxicol 15:17. 2014
  7. doi request reprint Comparing treatment-seeking codeine users and strong opioid users: Findings from a novel case series
    Suzanne Nielsen
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, Australia
    Drug Alcohol Rev 34:304-11. 2015
  8. doi request reprint Diversion of prescribed opioids by people living with chronic pain: results from an Australian community sample
    Jessica Belcher
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Drug Alcohol Rev 33:27-32. 2014
  9. pmc Comparing buprenorphine induction experience with heroin and prescription opioid users
    Suzanne Nielsen
    UCLA Integrated Substance Abuse Programs, Los Angeles, CA 90025, USA
    J Subst Abuse Treat 43:285-90. 2012
  10. pmc The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample
    Suzanne Nielsen
    UCLA Integrated Substance Abuse Programs, Los Angeles, California University of Sydney, Camperdown, New South Wales, Australia
    Am J Addict 23:343-8. 2014

Collaborators

Detail Information

Publications13

  1. ncbi request reprint The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids
    Suzanne Nielsen
    Discipline of Addiction Medicine, University of Sydney, Sydney, NSW, Australia
    Med J Aust 199:696-9. 2013
    ..To describe benzodiazepine and prescription opioid use by clients of drug treatment services and the sources of pharmaceuticals they use...
  2. pmc A comparison of buprenorphine taper outcomes between prescription opioid and heroin users
    Suzanne Nielsen
    UCLA Integrated Substance Abuse Programs, Los Angeles, CA, USA
    J Addict Med 7:33-8. 2013
    ....
  3. doi request reprint Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization
    Suzanne Nielsen
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia The Langton Centre, South East Sydney Local Health District SESLHD Drug and Alcohol Services, Sydney, New South Wales, Australia
    Pain Med 16:356-66. 2015
    ..This article aims to: describe patterns of BZDs use; the demographic, physical, and mental health correlates of BZD use; and examine if negative health outcomes are associated with BZD use after controlling for confounders...
  4. doi request reprint The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain
    Gabrielle Campbell
    aNational Drug and Alcohol Research Centre, School of Medicine, University of New South Wales, Sydney, Australia bThe Langton Centre, South East Sydney Local Health District SESLHD Drug and Alcohol Services, Surry Hills, Australia cSchool of Medicine, University of Tasmania, Sandy Bay Campus, Hobart, Australia dUniversity of Sydney, Addiction Medicine, Central Clinical School, Camperdown, Australia eSt Vincent s Clinical School, University of New South Wales, Darlinghurst, Australia fCentre for Youth Substance Abuse Research, Royal Brisbane and Women s Hospital, University of Queensland, Herston, Australia gSchool of Population and Global Health, The University of Melbourne, Melbourne, Australia hMurdoch Childrens Research Institute, The Royal Children s Hospital, Parkville, Australia iDepartment of Global Health, School of Public Health, University of Washington, Seattle, WA, USA
    Pain 156:231-42. 2015
    ..Major age-related differences in the experiences of pain, coping, mental health, and substance use suggest the necessity of differential approaches to treatment. ..
  5. pmc Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology
    Larissa J Mooney
    UCLA Integrated Substance Abuse Programs, Los Angeles, CA 90025, USA
    Contemp Clin Trials 34:196-204. 2013
    ..This paper describes the design and rationale for this study...
  6. pmc Cohort protocol paper: the Pain and Opioids In Treatment (POINT) study
    Gabrielle Campbell
    National Drug and Alcohol Research Centre, UNSW, Sydney, NSW 2052, Australia
    BMC Pharmacol Toxicol 15:17. 2014
    ....
  7. doi request reprint Comparing treatment-seeking codeine users and strong opioid users: Findings from a novel case series
    Suzanne Nielsen
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, Australia
    Drug Alcohol Rev 34:304-11. 2015
    ....
  8. doi request reprint Diversion of prescribed opioids by people living with chronic pain: results from an Australian community sample
    Jessica Belcher
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Drug Alcohol Rev 33:27-32. 2014
    ..This study investigated the extent to which an Australian community sample of chronic pain patients prescribed opioids reported supplying their prescribed opioids to others...
  9. pmc Comparing buprenorphine induction experience with heroin and prescription opioid users
    Suzanne Nielsen
    UCLA Integrated Substance Abuse Programs, Los Angeles, CA 90025, USA
    J Subst Abuse Treat 43:285-90. 2012
    ..The findings of this study suggest that existing buprenorphine induction practices developed for heroin users appear to be equally effective with PO users...
  10. pmc The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample
    Suzanne Nielsen
    UCLA Integrated Substance Abuse Programs, Los Angeles, California University of Sydney, Camperdown, New South Wales, Australia
    Am J Addict 23:343-8. 2014
    ..Our hypothesis, based on previous research and current guidelines, is that those on longer-acting opioids will have experienced more difficult inductions...
  11. doi request reprint A cross-sectional analysis of over-the-counter codeine use among an Australian sample of people who regularly inject drugs
    Sheena Arora
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia Centre for Health Economics and Research Evaluation, University of Technology, Sydney, Australia
    Drug Alcohol Rev 32:574-81. 2013
    ....
  12. doi request reprint Correlates of pain in an in-treatment sample of opioid-dependent people
    Suzanne Nielsen
    Discipline of Addiction Medicine, The University of Sydney, Sydney, Australia
    Drug Alcohol Rev 32:489-94. 2013
    ..Our hypothesis is that pain may increase aberrant opioid-related behaviours, including illicit substance use, among opioid-dependent people...
  13. doi request reprint Benzodiazepines, methadone and buprenorphine: interactions and clinical management
    Nicholas Lintzeris
    Sydney South West Area Health Service and University of Sydney, Sydney, Australia
    Am J Addict 19:59-72. 2010
    ..An overview of treatment approaches for managing BZD use in this population is presented, including strategies for minimizing abuse and addressing BZD dependence...